500+
Studies Published
40+
Active Trials
IRB
Approved Protocol
100%
Open Access
The systematic investigation into and study of materials, sources, and clinical phenomena in order to establish facts, validate hypotheses, and advance the standards of precision medicine.
Focus Areas
Biomarker discovery, translational science, clinical trial design, real-world evidence, and outcomes research, all anchored in IRB-approved, peer-reviewed standards of inquiry.
The Research at the American Board of Precision Medicine drives the evidence base that underpins clinical certification generating and synthesizing knowledge across multi-omics, therapeutics, and population health to inform standards that physicians can trust.
From biomarker discovery and translational studies to large-scale clinical trials and real-world outcomes analysis, this department connects bench science to boardroom policy ensuring every standard ABOPM sets is grounded in rigorous, reproducible evidence.
Research at ABOPM is not peripheral - it is the engine of credibility that keeps precision medicine standards current, defensible, and clinically meaningful.
500+
Studies Published
40+
Active Trials
IRB
Approved Protocol
The Research at ABOPM exists at the intersection of scientific inquiry and clinical practice generating the rigorous, reproducible evidence that drives certification standards, informs physician training, and advances the field of precision medicine.
Identifying and validating biological markers that predict disease onset, progression, and therapeutic response building the molecular evidence base for precision diagnostics and targeted treatment.
Designing and overseeing IRB-approved studies that test precision medicine interventions at scale from early-phase translational research to real-world outcomes analysis across diverse patient populations.
Accelerating the journey from bench discovery to bedside application synthesizing multi-omics data, population studies, and clinical evidence into actionable standards physicians can apply today.
"Research is not what happens before medicine - it is the engine that keeps medicine honest, current, and worthy of patient trust. At ABOPM, every standard we set begins with evidence."
American Board of Precision Medicine · Research DepartmentAs precision medicine continues to evolve, genomics will play an increasingly central role in redefining how disease is understood, predicted, and treated at the molecular level.
The Genomics Department at ABOPM remains committed to advancing this field through scientific leadership, clinical innovation, and collaborative discovery. Together with our global community of physicians and researchers, we are helping shape the future of next-generation healthcare.
Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.

Tumor genomic profiling helps identify actionable mutations to guide targeted therapies and clinical decisions. Understanding when to use it is key to maximizing its impact in precision oncology. ...more
Precision Oncology
May 07, 2026•8 min read

Genomic diversity is essential for accurate, equitable precision medicine. Expanding representation in research improves risk prediction, variant interpretation, and ensures better outcomes for all po... ...more
Population Precision
April 23, 2026•8 min read

Multi-omics medicine integrates genomics, transcriptomics, proteomics, and metabolomics to provide a comprehensive view of disease biology. By analyzing multiple molecular layers together, it enables ... ...more
On the Frontier
April 15, 2026•8 min read
Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.